What is the appropriate workup for a patient presenting with hematuria and flank (kidney) pain?

Workup for Blood in Urine with Kidney Pain

For a patient presenting with hematuria and flank pain, obtain a non-contrast CT scan of the abdomen and pelvis as the primary diagnostic imaging study 1.

Algorithmic Approach to Workup

Step 1: Initial Clinical Assessment

Focus your history on these specific red flags:

• Age >35 years and male gender (higher malignancy risk)
• Gross vs. microscopic hematuria (gross hematuria carries 30-40% malignancy risk vs. 2.6-4% for microscopic) 2
• Smoking history, occupational chemical exposure, chronic UTIs, or pelvic irradiation (all increase urologic malignancy risk) 2
• Acute onset of severe flank pain (suggests stone disease) 1

Step 2: Laboratory Studies

• Urinalysis (document degree of hematuria)
• Urine culture if infection suspected (obtain BEFORE antibiotics) 2
• Note: Absence of hematuria does NOT exclude urolithiasis—15% of patients with ureteral stones and 45% with renal stones may lack microhematuria 3

Step 3: Imaging Selection

Primary imaging: Non-contrast CT abdomen/pelvis 1

• Sensitivity 96-100% and specificity 98-100% for stones 1
• Detects virtually all radiopaque stones regardless of size 1
• Simultaneously evaluates for other causes of flank pain
• No IV contrast needed for initial stone evaluation

Alternative imaging scenarios:

If CT is contraindicated or unavailable:

• Ultrasound kidneys/bladder with targeted color Doppler (for twinkling artifact assessment) plus KUB radiograph 1
• Combined sensitivity 79-90% for stones, though inferior to CT 1
• US alone is 100% sensitive for hydronephrosis but may miss stones in first 2 hours before obstruction develops 1

If gross hematuria without acute pain:

• CT urography (CTU) is preferred 2
• Requires non-contrast phase PLUS nephrographic phase PLUS excretory phase (≥5 minutes post-contrast) 2
• Specifically tailored to evaluate entire urinary tract for malignancy

Step 4: Risk Stratification for Malignancy

High-risk patients requiring full urologic workup (CTU + cystoscopy):

• All patients with gross hematuria 2
• Microhematuria with risk factors: age >35, male, smoking, occupational exposures, chronic UTI, irritative voiding symptoms 2

Low-risk patients (may defer extensive imaging):

• Microhematuria with identified benign cause: vigorous exercise, menstruation, recent urologic procedure, confirmed UTI 2
• Critical caveat: Even on anticoagulation, hematuria requires full evaluation—anticoagulant use does NOT alter the workup 2

Common Pitfalls to Avoid

1. Don't assume hematuria confirms stone disease: 23% of patients with renal stones and 15% with ureteral stones have no hematuria 3

2. Don't order contrast-enhanced CT first: IV contrast obscures stones in the collecting system and reduces sensitivity to 81% overall (though 98% for stones ≥6mm) 1

3. Don't skip malignancy evaluation in older patients: Gross hematuria signals malignancy in 30-40% of cases 2

4. Don't rely on ultrasound alone: While US detects hydronephrosis well, it misses 25% of ureteral stones even when hydronephrosis is present 1

5. Don't delay imaging in suspected renal infarction: Consider this in patients with cancer history, as malignancy creates hypercoagulable state—look for the triad of flank pain, hematuria, and elevated LDH 4

When to Escalate Care

Immediate urology consultation needed for:

• Uncontrolled pain despite NSAIDs/analgesics
• Fever (suggests infected obstructed system)
• Oliguria/anuria (complete obstruction)
• Hemodynamic instability

Nephrology consultation indicated for:

• Signs of glomerulonephritis (RBC casts, proteinuria, renal insufficiency)
• Suspected acute kidney injury or acute tubular necrosis 2

The evidence strongly supports non-contrast CT as first-line imaging, with CTU reserved for malignancy evaluation in high-risk patients. Ultrasound serves as a reasonable alternative when CT is unavailable, but its limitations must be recognized.